Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|24|2812-2818

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.24, 2015-01, pp. : 2812-2818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-steroidal anti-inflammatory drugs in cancer treatment

By Cuendet Muriel   Pezzuto John M  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 827-835

Informa Healthcare

Access to resources Recommend Favorite

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

By Charlier C.   Michaux C.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 645-659

Elsevier

Access to resources Recommend Favorite

Colon Cancer: A Role for Cyclo-oxygenase-2-Specific Nonsteroidal Anti-Inflammatory Drugs

By Reddy B.S.   Rao C.V.  

Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. : 329-334

Adis International

Access to resources Recommend Favorite

Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer 's Disease

By  

Current Drug Targets, Vol. 4, Iss. 6, 2003-08 ,pp. : 461-468

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 Inhibition, Apoptosis, and Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.

By  

Current Medicinal Chemistry, Vol. 7, Iss. 11, 2000-11 ,pp. : 1131-1144

Bentham Science Publishers

Access to resources Recommend Favorite